Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Maryna Yarotska"'
Autor:
Jen C Wang, Guanfang Shi, Stacey Baptiste, Maryna Yarotska, Hemant Sindhu, Ching Wong, Madhumati Kalavar, Vladimir Gotlieb, Andrei Bandarchuk, Hui Chen
Publikováno v:
PLoS ONE, Vol 11, Iss 11, p e0165299 (2016)
Endogenous erythroid colony (EEC) formation is one of the minor criteria for diagnosing polycythemia vera (PV) according to 2008 WHO diagnostic criteria. But EEC requires bone marrow aspiration and sophisticated laboratory procedures; therefore, prac
Externí odkaz:
https://doaj.org/article/bbf472abbe104baf9494e57151db5661
Autor:
Andrei Bandarchuk, Stacey Baptiste, Jen C. Wang, Ching Wong, Hui Chen, Madhumati Kalavar, Vladimir Gotlieb, Maryna Yarotska, Hemant Sindhu, Guanfang Shi
Publikováno v:
PLoS ONE
PLoS ONE, Vol 11, Iss 11, p e0165299 (2016)
PLoS ONE, Vol 11, Iss 11, p e0165299 (2016)
Endogenous erythroid colony (EEC) formation is one of the minor criteria for diagnosing polycythemia vera (PV) according to 2008 WHO diagnostic criteria. But EEC requires bone marrow aspiration and sophisticated laboratory procedures; therefore, prac
Autor:
Cherif Abdelmalek, Jen-Chin Wang, Guanfang Shi, Ching Wong, Hui Chen, Madhumati Kalaovar, Vladimir Gotlieb, Maryna Yarotska
Publikováno v:
Cancer Research. 76:3293-3293
Introduction Although MPNs have been regarded as stem cell disease. Recent evidence suggest that chronic inflammation induces a state of chronic oxidative stress with elevated reactive oxygen species (ROS) and then induce alternation in epigenetic ch
Autor:
Vladimir Gottlib, Ching Wong, Hui Chen, Jen-Chin Wang, Madhumati Kalavar, Abdelmalek Cherif, Guanfang Shi, Maryna Yarotska
Publikováno v:
Blood. 126:5202-5202
Introduction Myeloproliferative neoplasms (MPNs) are associated with constitutional symptoms and high levels of circulating inflammatory cytokines. The etiology of this increase in inflammatory cytokines could be secondary to Jak2 mutation resulting
Publikováno v:
Blood. 126:5203-5203
Introduction. Ruxolitinib is the first JAK1/JAK2 inhibitor to be approved by the US Food and Drug Administration for the treatment of myelofibrosis (MF) and polycythemia vera (PV). Ruxolitinib is beneficial in relieving constitution symptoms and redu
Autor:
Stacey Baptiste, Maryna Yarotska, Ching Wong, Jen-Chin Wang, Vladimir Gotlieb, Guanfang Shi, Hemant Sindhu, Madhumati Kalavar
Publikováno v:
Blood. 124:3226-3226
Endogenous erythroid colony formation in vitro is one of the important criteria for the diagnosis of polycythemia vera (PV). Extensive studies performed in the last decade suggest that IGF-1 plays a significant role in the erythropoiesis and endogeno